Greece

ProBiotix Health has announced two commercial partnerships for the distribution of its probiotic ingredients, with Deutsch-Pharm in Ukraine and Eifron in Greece respectively.

Having earlier this year outlined plans for international expansion, liquids specialist Rosemont has made its first venture outside the UK by acquiring Greek R&D organization Pharma-Data.

J&J says it has “exhausted all current viable avenues” to get its antidepressant nasal spray Spravato reimbursed on England’s National Health Service, after NICE decided against re-appraising the drug following numerous funding rejections.

Haleon has launched in Europe nasal spray technology under the Otrivin brand that is the result of a seven year partnership with Aptar Pharma. Otrivin Nasal Mist’s design is a “significant improvement on other pump devices,” Haleon claims.

CNS specialist Neuraxpharm has snapped up the Lazap olanzapine brand in Greece from local firm Lyofin, helping to further expand its presence in the Greek market following a recent acquisition.

Privately-owned Neuraxpharm has found another company to give it further access to a new European market, picking up Athens-based Brain Therapeutics. It aims now to introduce its Buccolam (midazolam) in Greece.

Major European, US and international off-patent industry events are switching back to being held in person in the second half of 2021, after a sustained period of largely digital-only interactions.

Zentiva has struck a new partnership to expand its already significant operations in Europe, this time in Greece with local firm Lavipharm.

Gerolymatos International's Sinomarin seawater-based nasal spray is now distributed in France by Laboratoire Gifrer.

In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers events at the national, EU and global level.